Catalysts
IQV Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
IQV
CatalystsStock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 78/100 and sentiment — before the next covered event.
Updated Sep 7, 2026 · Sentiment 33.87%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | — | $3.03 | $3.15 | +4.0% | $4.3B | $4.37B |
| May 5, 2026 | — | $2.82 | $2.90 | +2.8% | $4.1B | $4.15B |
| Feb 5, 2026 | — | $3.40 | $3.42 | +0.6% | $4.24B | $4.36B |
| Oct 28, 2025 | — | $2.98 | $3.00 | +0.7% | $4.08B | $4.1B |
| Jul 22, 2025 | — | $2.77 | $2.81 | +1.4% | $3.97B | $4.02B |
| May 6, 2025 | — | $2.63 | $2.70 | +2.7% | $3.77B | $3.83B |
| Feb 6, 2025 | — | $3.11 | $3.12 | +0.3% | $3.93B | $3.96B |
| Oct 31, 2024 | — | $2.82 | $2.84 | +0.7% | $3.87B | $3.9B |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?
Despite already outperforming the broader market over the past year, IQVIA continues to enjoy strong backing from Wall Street, with analysts remaining highly optimistic about the stock’s future prospects.
The Backlog Tells the Real Story: Inside IQVIA’s Blowout Q2
The global healthcare ecosystem in 2026 is leading to a strong recovery in clinical research, with global pharma R&D investment topping $250 billion and the clinical research organization (CRO) market rising to $72 billion at roughly a 9% annual pace. As biopharma companies move capital into complex biologic pipelines, AI-powered trial improvement, and practical data […]
Related Links
IQV Catalysts FAQ
What are the next catalysts for IQV stock?
IQV's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move IQV stock?
Upcoming events that could move IQV include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could IQV's next earnings report affect the stock?
IQV's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive IQV stock higher?
IQV could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt IQV stock?
IQV could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.